Alternating chemoradiotherapy in patients with nasopharyngeal cancer: Prognostic factors and proposal for individualization of therapy

Journal of Radiation Research

Volumn 54, Issue 1, 2013, Pages 98-107

  Goto, Yoko ^a   Kodaira, Takeshi ^a   Fuwa, Nobukazu ^a   Mizoguchi, Nobutaka ^a   Nakahara, Rie ^a   Nomura, Motoo ^a   Tomita, Natsuo ^a   Tachibana, Hiroyuki ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

alternating chemoradiation; nasopharyngeal carcinoma; WHO type I histopathology

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DIAGNOSIS; DISEASE CONTROL; DISEASES; HISTOLOGY; RADIOTHERAPY; TOXICITY;

5-FLUOROURACIL; ALTERNATING CHEMORADIATION; CHEMO RADIATIONS; MULTI VARIATE ANALYSIS; NASOPHARYNGEAL CANCER; NASOPHARYNGEAL CARCINOMA; OVERALL SURVIVAL; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; WHO TYPE I HISTOPATHOLOGY;

MULTIVARIANT ANALYSIS;

EID: 84872010166     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs071     Document Type: Article

References (16)

1. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-7.
2. Lin JC, Jan JS, Hsu CY et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7.
3. Chen Y, Liu MZ, Liang SB et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 2008;71:1356-64.
4. Lee AW, Lau WH, Tung SY et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 2005;23:6966-75.
5. Baujat B, Audry H, Bourhis J et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006;64:47-56.
6. Greene FL, Page DL, Fleming ID et al. AJCC cancer staging handbook from the AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
7. Fuwa N, Ito Y, Kodaira T et al. Therapeutic results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: Its usefulness and controversial points. Jpn J Clin Oncol 2001;31:589-95.
8. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events version 3.0 (CTCAE). Bethesda: Chemoradiotherapy for hypopharyngeal cancer 9 National Cancer Institute, 2003. http://ctep.cancer.gov/ forms/CTCAEv3. pd.f.
9. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:475-81.
10. Fuwa N, Kano M, Toita T et al. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: A preliminary report of phase II study. Radiother Oncol 2001;61:257-60.
11. Ou SH, Zell JA, Ziogas A et al. Epidemiology of nasopharyngeal carcinoma in the United States: Improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 2007;18:29-35.
12. Kawashima M, Fuwa N, Myojin M et al. A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma. Jpn J Clin Oncol 2004;34:569-83.
13. Lee N, Harris J, Garden AS et al. Intensity-Modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3784-90.
14. Kodaira T, Tomita N, Tachibana H et al. Aichi Cancer Center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys 2009;73:1129-34.
15. Kwong DL, Sham JS, Leung LH et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;64:374-81.
16. Lorch JH, Goloubeva O, Haddad RI et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: Long-term results of the TAX324 randomised phase 3 trial. Lancet Oncol 2011;12:153-9.